Science Explorer Interactive view Map
Company · South San Francisco · United States

Catalyst Biosciences (United States)

catalystbiosciences.comROR OpenAlex
Research works
17
▲ 635% vs 2013–17
Citations
225
13.2 per fractional work
Top-10% rate
7.8%
record average 16.5%
Open access
50%
world 28%

Not ranked overall: Catalyst Biosciences (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.73× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 10.34× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 10.88× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.60× its world share, 0 worksComputer ScienceMaterials Science: 1.10× its world share, 0 worksMaterials ScienceMedicine: 3.54× its world share, 3 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 10.9×. Every wedge is a field page.

Which research topics does Catalyst Biosciences (United States) publish most on?

By volume in 2022–2025: Hemophilia Treatment and Research, Platelet Disorders and Treatments, CAR-T cell therapy research and Computational Drug Discovery Methods.

Hemophilia Treatment and…1Hemophilia Treatment and Research: 1 fractional worksPlatelet Disorders and Treatments: 0 fractional worksCAR-T cell therapy research: 0 fractional worksComputational Drug Discovery Methods: 0 fractional worksChronic Myeloid Leukemia Treatments: 0 fractional worksBlood transfusion and management: 0 fractional worksvaccines and immunoinformatics approaches: 0 fractional worksComplement system in diseases: 0 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksNanoparticle-Based Drug Delivery: 0 fractional works
HematologyOncologyComputational Theory and MathematicsBiochemistry4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Hemophilia Treatment and Research Hematology 1 works
  2. 2 Platelet Disorders and Treatments Hematology 0 works
  3. 3 CAR-T cell therapy research Oncology 0 works
  4. 4 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  5. 5 Chronic Myeloid Leukemia Treatments Hematology 0 works
  6. 6 Blood transfusion and management Biochemistry 0 works
  7. 7 vaccines and immunoinformatics approaches Molecular Biology 0 works
  8. 8 Complement system in diseases Immunology 0 works
  9. 9 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  10. 10 Nanoparticle-Based Drug Delivery Biomaterials 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available49.8%not open50.2%

World: 28% of research is openly available.

with international co-authors42.5%domestic only57.5%

World: 19% is written across borders.

How has Catalyst Biosciences (United States)'s research output changed?

Output in 2018–2022 was 635% higher than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in South San Francisco

All research institutions in South San Francisco

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.